University of Wisconsin–Madison

Archive: Dr. Hans Sollinger’s new venture featured in WisBusiness

Hans W. Sollinger, MD, PhD, FACS, Professor of Surgery and founder of Insulete Inc. has been performing pancreatic transplants for the treatment of Type I diabetes for decades. While the surgeries can be successful, they can also have several complications: costs are high, donors are hard to find and patients must endure immune-suppression after receiving the new pancreas. Insulete stands for “insulin obsolete,” since Dr. Sollinger hopes to make daily insulin injections, the only other current therapy for type I diabetes, unnecessary.

Click here to read more about Dr. Sollinger’s quest to eliminate daily insulin injections for patients with diabetes.